Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 136

    1.

    Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes.

    Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M.

    Diabetes Care. 2007 Mar;30(3):719-21. No abstract available. PMID: 17327348 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus.

    Hui-Bing H, Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K, Kimura H.

    Metabolism. 2006 Dec;55(12):1670-3.PMID: 17142142 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes.

    Cruz M, Maldonado-Bernal C, Mondragón-Gonzalez R, Sanchez-Barrera R, Wacher NH, Carvajal-Sandoval G, Kumate J.

    J Endocrinol Invest. 2008 Aug;31(8):694-9.PMID: 18852529 [PubMed - indexed for MEDLINE]Related articles

    4.

    Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus.

    Hsieh CH, He CT, Lee CH, Wu LY, Hung YJ.

    Metabolism. 2007 Aug;56(8):1087-92.PMID: 17618954 [PubMed - indexed for MEDLINE]Related articles

    5.

    Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.

    Mojiminiyi OA, Abdella NA.

    Scand J Clin Lab Invest. 2007;67(2):215-25.PMID: 17366001 [PubMed - indexed for MEDLINE]Related articles

    6.

    The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.

    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M.

    Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):837-43.PMID: 18043308 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Effect of yuquan pill on proinflammatory cytokines in patients with type 2 diabetes mellitus]

    Deng YQ, Fan XF, Wu GL.

    Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Aug;26(8):706-9. Chinese. PMID: 16970093 [PubMed - indexed for MEDLINE]Related articles

    8.

    [The role of inflammation factors in development of acute coronary syndrome in patients with type 2 diabetes mellitus and impaired glucose tolerance]

    Chazova TE, Masenko VP, Zykov KA, Golitsyna TIu.

    Ter Arkh. 2007;79(6):60-4. Russian. PMID: 17684970 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.

    Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou E, Tsioufis C, Stefanadi E, Latsios G, Tentolouris C, Siasos G, Stefanadis C.

    Clin Cardiol. 2007 Jun;30(6):295-300.PMID: 17551966 [PubMed - indexed for MEDLINE]Related articles

    10.

    Inflammatory cytokines in insulin-treated patients with type 2 diabetes.

    Mavridis G, Souliou E, Diza E, Symeonidis G, Pastore F, Vassiliou AM, Karamitsos D.

    Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):471-6. Epub 2007 Oct 31.PMID: 17976964 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

    Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH.

    Eur J Endocrinol. 2007 May;156(5):595-602.PMID: 17468196 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.

    De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ.

    Diabetes Care. 2007 Oct;30(10):2511-3. Epub 2007 Jul 12. No abstract available. PMID: 17626892 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.

    von Eynatten M, Schneider JG, Hadziselimovic S, Hamann A, Bierhaus A, Nawroth PP, Dugi KA.

    Diabetes Care. 2005 Mar;28(3):754-5. No abstract available. PMID: 15735224 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.

    Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X.

    Eur J Endocrinol. 2008 Nov;159(5):585-93. Epub 2008 Aug 27.PMID: 18753313 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Serum resistin is associated with the severity of microangiopathies in type 2 diabetes.

    Osawa H, Ochi M, Kato K, Yamauchi J, Nishida W, Takata Y, Kawamura R, Onuma H, Takasuka T, Shimizu I, Fujii Y, Ohashi J, Makino H.

    Biochem Biophys Res Commun. 2007 Apr 6;355(2):342-6. Epub 2007 Feb 5.PMID: 17303077 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of resistin in inflammation and inflammation-related diseases.

    Pang SS, Le YY.

    Cell Mol Immunol. 2006 Feb;3(1):29-34. Review.PMID: 16549046 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

    Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T.

    Metabolism. 2007 Apr;56(4):451-8.PMID: 17378999 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.

    Castoldi G, Galimberti S, Riva C, Papagna R, Querci F, Casati M, Zerbini G, Caccianiga G, Ferrarese C, Baldoni M, Valsecchi MG, Stella A.

    Clin Sci (Lond). 2007 Jul;113(2):103-8.PMID: 17362204 [PubMed - indexed for MEDLINE]Related articles

    19.

    Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.

    On YK, Park HK, Hyon MS, Jeon ES.

    Circ J. 2007 Jun;71(6):868-73.PMID: 17526982 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.

    Akalin A, Alatas O, Colak O.

    Eur J Endocrinol. 2008 Jan;158(1):47-52.PMID: 18166816 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data